4.4 Article

The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants

Journal

REPRODUCTIVE TOXICOLOGY
Volume 30, Issue 1, Pages 200-218

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.reprotox.2010.05.012

Keywords

In vitro tests; Alternative reproductive toxicity testing; Ring trial; Endocrine disruption; Fertility; Embryotoxicity

Funding

  1. ECVAM [CCR.IHCP.C432976.X0]
  2. European commission [LSHB-CT-2004-503257]

Ask authors/readers for more resources

ReProTect is a project within the 6th European Framework Program which has developed alternative methods aimed to reduce or replace animal experimentation in the field of reproductive toxicology. In its final year, a ring trial, named the Feasibility Study, was conducted, in which 10 blinded chemicals with toxicologically well-documented profiles were analyzed by employing a test battery of 14 in vitro assays. EC50 (half maximal effective concentration) or equivalent endpoints were determined and the test compounds were ranked relative to chemicals previously assayed in the tests of the battery. This comparative analysis together with a weight of evidence approach allowed a robust prediction of adverse effects on fertility and embryonic development of the 10 test chemicals in vivo. In summary, the vast majority of the predictions made based on the in vitro results turned out to be correct when compared to the whole animal data. The procedure used here, a nearest neighbor analysis coupled with a weight of evidence approach, may guide future activities in the field of alternative toxicity testing. (C) 2010 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available